A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first symptoms of ...
Jan 22, 2024
0
43
Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test ...
Jan 22, 2024
0
55
Type 2 diabetes patients have access to an assortment of digital health tools, including mobile apps for iPhones and remote patient monitoring devices, all of which help them manage their blood glycemic levels. They can test ...
Jan 22, 2024
0
16
A multicenter study led by Amsterdam UMC and conducted in nine Dutch Intensive Care Units (ICUs) has shown that tailoring a computerized decision support system (CDSS) to the ICU environment significantly reduced the number ...
Jan 20, 2024
0
36
There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily. Now, they may soon have a new alternative to syringes or insulin pumps. Scientists ...
Jan 19, 2024
1
145
Patients with Guillain-Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness. In Europe and the U.S., ...
Jan 19, 2024
0
49
The first documented case of pancreatic cancer dates back to the 18th century. Since then, researchers have undertaken a protracted and challenging odyssey to understand the elusive and deadly disease. To date, there is no ...
Jan 18, 2024
0
43
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors' potential to spread, and may even be targets for future prostate cancer treatments, according ...
Jan 18, 2024
0
26
Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of manifestations. Long COVID's causes ...
Jan 18, 2024
0
18
Researchers at Karolinska Institutet and SciLifeLab demonstrate in a new study published in iScience how they can identify substances that can deactivate an enzyme responsible for chemotherapy resistance in cancer cells. ...
Jan 18, 2024
0
27
